-
Mashup Score: 0Alemtuzumab (Lemtrada) - Cambridge Neuroimmunology - 2 year(s) ago
The history of alemtuzumab use in multiple sclerosis The University of Cambridge has made a video on the history of alemtuzumab and published an article covering similar ground here. The beginnings of Alemtuzumab Campath-1H (now called alemtuzumab) was originally synthesized by Herman Waldmann at the Department of Pathology in Cambridge University (hence Cam-Path). Campath was licensed […]
Source: Cambridge NeuroimmunologyCategories: Hem/Oncs, Latest HeadlinesTweet
Now a bit of hx: Campath-1H (alemtuzumab) was originally synthesized by Herman Waldmann at the Department of Pathology in Cambridge University (hence Cam-Path 💡). Read about it here https://t.co/zVTAa4DaMR #WHOHEME @AaronGoodman33 https://t.co/X57XaSqlyX